- About bilaterals.org
- How to participate
- Key issues
- Texts of agreements
Ranbaxy deal may help India’s entry into Japan
Financial Express | June 14, 2008
Ranbaxy deal may help India’s entry into Japan
New Delhi, Jun 13 — The Daiichi Sankyo-Ranbaxy Laboratories deal has come as a shot in the arm for India’s Comprehensive Economic Co-operation Agreement (CECA) negotiations with Japan. Indian pharma companies have been unable to break into Japan, the world’s second largest drug market, due to the country’s stringent sanitary and phytosanitary standards, technical barriers to trade (TBT) and environmental norms.
"The acquisition of Ranbaxy is arecognition of the quality of Indian drug and other pharma products bytheir Japanese counterparts. Before signing the CECA (Comprehensive Economic Cooperation Agreement), we will now aggressively push the case of our pharma sector as well as that of the chemicals, bio-tech and cosmetics sectors to ensure that Japan agrees to opening up their market for these products," a government official told FE.
Since the current Japanese standards on drugs and other pharmaceuticals products are higher than the accepted international standards, it amounts to a non-tariff barrier, the officialofficial added. India will ask Japan to bring their national standards to international levels and also ensure that there is a harmonization of SPS and TBT standards of both countries.
The government is, however, seeing the Ranbaxy deal as a bigger opportunity apart from getting a foothold in the $65 billion pharma market. In a bid to pave the way for the entry of Indian health industry into Japan, New Delhi would also pitch for relaxing the norms for movement of doctors, nurse and other health professionals from India to Japan.
Indian industry sees Japan’s drug approval procedures as stricter and time-consuming. Besides, it is also mandatory to get such products are tested in Japan itself as they do not accept products tested outside that country.
India would now demand that if the US FDA (Food and Drug Administration) has given approval to a drug, Japan must also allow it without any further testing. The government is also keeping a close watch on the deal’s impact on the Indian pharma market and if it would result in costlier drugs entering the country.
Join the Global Day of Action against free trade agreements and investment treaties - 18 April 2015 - #April18DoA - https://www.globaltradeday.org
News from the movements
17-Apr-2015 Left Foot ForwardThis slew of trade deals can be seen as a global corporate offensive – indeed, they are backed by networks of think tanks and lobby groups funded and staffed by some of the world’s most powerful corporations. So to defeat them, we need to coordinate our own actions globally.
17-Apr-2015 El DiarioEl próximo 18 de abril es el segundo día internacional de lucha contra el Tratado Transatlántico de Comercio e Inversiones (TTIP).
16-Apr-2015Multi-sectoral network calls on Philippine government to turn back from its FTA ambitions
16-Apr-2015 CETIMCe livre de Yash Tandon montre comment l’OMC, les Accords de partenariat économique (APE) et le Grand marché transatlantique (TAFTA ou TTIP) sont imprégnés d’une idéologie masquant un système qui ne roule que dans l’intérêt des entreprises transnationales.
16-Apr-2015 Dynamic BusinessThe Australian Council of Trade Unions (ACTU) is calling for the federal government to halt all negotiations on “the secret Trans-Pacific Partnership (TPP) trade deal”, saying that the leaked proposals could see the price of medicines rise and foreign companies given rights to sue the Government.
CETA draft: Important positions taken by the French National Assembly also relevant for TTIP/TAFTA and the EPAsOn the 23 November 2014, the French National Assembly adopted a resolution whose importance cannot escape the attention of citizens who are opposed to the EU-Canada, EU-US and similar trade agreements.
15-Apr-2015 ITUCThe International Trade Union Confederation calls on the government of El Salvador to denounce all treaties establishing ISDS proceedings.
15-Apr-2015Inquieta el silencio del Ministerio de Industria, Comercio y Turismo de Colombia, y en particular, la tentativa de aceptar la sobretasa ilegal ecuatoriana, rebajada al 25 por ciento, mientras pregona a los cuatro vientos que por ley hay condiciones de libre comercio con el vecino país.
bilaterals.org is a collaborative space to share information and support movements struggling against bilateral trade and investment deals which serve corporations, not people. Multilingual. Global. No one owns it. Open publishing. Join us.